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            Serpins are found in most branches of 
life, including animals, plants, viruses, 
and prokaryotes. They are critical in the 
control of numerous proteolytic cascades 
in man, including those involved in in-
fl  ammation (      1  -antitrypsin and       1  -anti-
chymotrypsin), thrombosis (antithrombin, 
heparin cofactor II, and protease nexin-
1), and the complement cascade (C1-in-
hibitor). Serpins are defi  ned by at least 
30% sequence identity with the arche-
typal member       1  -antitrypsin and a com-
mon structural fold that is based on a 
fi  ve-stranded     -sheet and mobile-reac-
tive center loop. The binding of target 
proteinases to the reactive loop springs 
a remarkable   “  mousetrap  ”  -like mecha-
nism that fl  ips the enzyme from the apex 
to the base of the serpin (  Fig. 1  ).   This is 
associated with insertion of the reactive 
loop as an extra strand in     -sheet A and 
inactivation of the catalytic triad of the 
target protease (  1  ). This mechanism pro-
vides specifi  c and irreversible inhibition 
of enzymes, but the dramatic movement 
of the protein also renders serpins vulner-
able to aberrant conformational transi-
tions caused by point mutations. Many 
members of the serpin superfamily can be 
aff  ected by these mutations, which cause 
a diverse range of diseases, including cir-
rhosis, dementia, thrombosis, angio-
edema, and emphysema. We have termed 
this group of diseases the serpinopathies, 
based on their common molecular mech-
anism (  2  ). There is now a wealth of in-
formation on the structural transitions 
that underlie the serpinopathies, but 
much less is known about the cellular 
and tissue response to the aberrant pro-
tein conformers that cause disease. Here, 
we will discuss three distinct mechanisms: 
cell death due to intracellular accumula-
tion of mutant serpin, uncontrolled pro-
teolytic activity due to loss of serpin 
function, and tissue damage due to extra-
cellular deposition of mutant serpins. 
  Intracellular accumulation of mutant 
serpins: mechanism 1 
  Insights into the toxicity caused by the 
intracellular accumulation of mutant ser-
pins largely comes from work on       1  -anti-
trypsin defi  ciency, the best characterized 
of the serpinopathies.       1  -antitrypsin is 
synthesized in the liver and is constitu-
tively released into the circulation where 
it protects tissues against damage from 
the neutrophil enzyme elastase. The Z 
mutant of       1  -antitrypsin is found in 4% 
of the north European population and 
causes some of the newly synthesized 
protein to misfold and form ordered 
polymers (  Fig. 1  ) that are retained within 
the endoplasmic reticulum (ER) of he-
patocytes (  3, 4  ). The resulting protein 
overload predisposes individuals homo-
zygous for the Z mutation to neonatal 
hepatitis, cirrhosis, and   hepatocellular 
carcinoma. Other mutants of       1  -anti-
trypsin (    51Phe, Ser53Phe) also cause 
the protein to form ordered polymers 
and create a similar degree of protein 
overload. These mutations probably also 
predispose to liver disease, but their 
rarity makes it diffi   cult to undertake 
detailed epidemiological studies. The S 
(Glu264Val) and I (Arg39Cys) mutants 
of       1  -antitrypsin form polymers much 
less readily than the Z mutant and thus 
can be cleared by the normal disposal 
pathways within the cell. These mutants 
are not associated with liver disease un-
less they are inherited along with the 
more severe Z allele. Thus, there is a 
threshold eff  ect whereby the mutation 
must cause suffi   cient accumulation of 
polymers to cause disease. 
  Mutants of the brain-specifi  c serpin 
neuroserpin also form ordered poly-
mers that accumulate within the ER of 
neurons. These mutations cause an au-
tosomal-dominant dementia known 
as familial encephalopathy with neuro-
serpin inclusion bodies (FENIB) (  5  ). 
Similar to       1  -antitrypsin mutants, the 
neuroserpin mutants display a striking 
genotype  –  phenotype correlation: more 
severe mutations lead to faster polymer 
formation, more inclusions, and disease 
onset at a younger age. 
  How intracellular accumulation of 
mutant       1  -antitrypsin and neuroserpin 
polymers causes the cell death and in-
fl  ammation that characterize cirrhosis 
and FENIB is not completely clear. The 
intracellular pathways that respond to 
mutant serpins are now being elucidated. 
A majority of the mutated protein fails to 
fold and is degraded by the proteasome 
(  6  ), and 10  –  15% of the protein folds nor-
mally and is secreted into the plasma (in 
the case of Z       1  -antitrypsin). However, a 
small proportion of the mutant protein 
folds into ordered polymers, some of 
which are degraded by autophagy (  7  ) 
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protein that causes disease. This is exem-
plifi  ed by naturally occurring mutations 
in the plasma proteins C1-inhibitor, an-
tithrombin, and       1  -antichymotrypsin, 
which control the complement, coagu-
lation, and infl  ammatory cascades, re-
spectively. These mutations destabilize 
the protein  ’  s architecture, allowing the 
ing that activates NF-    B and caspases has 
yet to be elucidated. 
  Overactivity of proteolytic cascades: 
mechanism 2 
  Not all pathogenic serpin mutations re-
sult in the build up of toxic polymers. In 
some cases, it is the absence of functional 
and the remainder of which accumulates 
within the ER. Accumulation of the mu-
tant protein in the ER activates the tran-
scription factor nuclear factor    B (NF-   B) 
and caspases (  8  –  10  ), thereby inducing in-
fl  ammation and apoptosis. The mecha-
nism that prevents the exit of polymers 
from the ER and the consequent signal-
    Figure 1.         Conformational transitions of the serpins.   The reactive loop of     1  -antitrypsin (A, red) binds to neutrophil elastase (B, dark gray), triggering 
a conformational change that fl  ips the enzyme from the apex to the base of the serpin (C). This is associated with insertion of the reactive loop of the 
target proteinase as an extra strand into     -sheet A (blue) and inactivation of the catalytic triad of the protease. Point mutations subvert this mechanism 
and cause aberrant conformational transitions (D) and the formation of polymers (E and F).     JEM VOL. 205, July 7, 2008  1531
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in those who smoke). For many years, 
this type of emphysema was largely attrib-
uted to the lack of eff  ective antiprotein-
ase activity and control of infl  ammation 
within the lung (mechanism 2). How-
ever, the recognition that other path-
ways contribute to tissue damage in the 
serpinopathies requires a reconsideration 
of the pathogenesis of disease. 
  In emphysema, noxious stimuli such 
as cigarette smoke are thought to trig-
ger the initial infl  ammation within the 
lung. A chemotactic gradient of inter-
leukin (IL)-8 and leukotriene-B4 re-
cruits large numbers of macrophages 
and neutrophils from capillaries into the 
small airways and alveoli (  Fig. 2  ).   To 
reach the alveoli, the cells must migrate 
through an interstitial space that con-
tains elastin, proteoglycans, and colla-
gen, and then through the junctions 
between epithelial cells (  21, 22  ). In pa-
tients with emphysema, neutrophils are 
initially concentrated in the centrilob-
ular regions of the lung parenchyma 
where they release serine and cathep-
sin proteinases, which degrade elastin 
and other structural proteins and thus 
contribute to disease (  23  ). Degraded 
elastin fragments themselves act as che-
moattractants and recruit additional in-
fl  ammatory cells into the lungs (  24, 25  ). 
Emphysema is further exacerbated by 
free radicals contained in cigarette smoke 
(10 
17   per puff  ) and superoxide released 
by activated neutrophils, which damage 
proteins, lipids, and DNA (  26  ) and cause 
cell death. 
  As the major inhibitor of neutrophil 
elastase,       1  -antitrypsin is critical for de-
fense against such proteolytic lung dam-
age.       1  -Antitrypsin enters the lung by 
passive diff  usion from the circulation and 
is also secreted locally by macrophages and 
bronchial and alveolar epithelial cells. In 
individuals homozygous for the Z muta-
tion, however, all of the       1  -antitrypsin in 
the lungs has the propensity to form poly-
mers, regardless of its source. Indeed, 
polymers of       1  -antitrypsin are found in 
lavage (  18, 27  ) and tissue sections (  19  ) 
from the lungs of these individuals. De-
posits of polymers are particularly promi-
nent around capillaries (consistent with a 
circulating source of polymers) and epi-
thelial cells (consistent with local  synthesis). 
transfected with mutants of neuroserpin 
(  16  ). It is clearly important to consider 
whether extracellular polymers are in-
active bystanders or whether they can 
themselves exacerbate the tissue damage 
of the serpinopathies. 
  Recent work has shown that poly-
mers of       1  -antitrypsin are chemotactic 
for neutrophils in vitro and cause a neu-
trophil infl  ux when instilled into the 
lungs of mice (  17  –  19  ). In contrast, the 
monomeric protein has little eff  ect on 
the migration of neutrophils in vitro or 
in vivo. The infl  ux of infl  ammatory cells 
in mice treated with polymers is not me-
diated by chemokines, but appears to be 
a direct eff  ect of       1  -antitrypsin polymers 
on neutrophils. Neutrophil chemotaxis 
caused by systemic polymers may ex-
plain the well-recognized association be-
tween vascular disease associated with 
the presence of antibodies against neu-
trophil cytoplasmic components and the 
Z allele of       1  -antitrypsin (  20  ). In this 
case, polymers may cause the aberrant 
leukocyte migration that underlies the 
arteritis and capillaritis that causes organ 
damage. The infl  ammatory properties 
of polymers may also play a role in other 
serpinopathies. For example, the pres-
ence of neuroserpin polymers at the 
neuronal synapse may cause local infl  am-
mation, thus contributing to neuronal 
dysfunction and disruption of synap-
tic plasticity in FENIB. Infl  ammation 
caused by the tissue deposition of C1-
inhibitor polymers may exacerbate the 
vascular permeability that characterizes 
angio-edema. 
        1  -Antitrypsin polymers, infl  ammation, 
and emphysema 
  It is clear that all three mechanisms of 
serpin-mediated tissue damage may 
contribute to the pathogenesis of dis-
ease, although their contribution is likely 
to vary between serpins and serpinop-
athies. The interaction of the diff  erent 
pathways is perhaps best characterized 
for the type of emphysema that is asso-
ciated with       1  -antitrypsin defi  ciency. 
This accounts for 1  –  3% of all cases of 
chronic obstructive pulmonary disease. 
Individuals who are homozygous for the 
Z mutation typically develop panlobular 
emphysema in their 40s and 50s (or 30s 
formation of unstable intermediates and 
inactive polymers within the ER of he-
patocytes. However, as these proteins 
are less abundant (synthesized at 10% the 
rate of       1  -antitrypsin) and the mutations 
are usually heterozygous, the aberrant 
protein can be eff  ectively cleared by 
degradative pathways and does not form 
toxic inclusions. However, intrahepatic 
clearance of these mutant proteins leads 
to reduced secretion and a lack of func-
tional protein in the circulation. C1-in-
hibitor defi  ciency results in uncontrolled 
activity of the complement cascade and 
angio-edema; antithrombin defi  ciency 
causes thrombosis; and       1  -antichymo-
trypsin defi  ciency renders tissues vulner-
able to proteolytic attack, which can lead 
to infl  ammation and chronic obstructive 
pulmonary disease. 
  A mutation in the serpin heparin 
cofactor II, which normally inhibits co-
agulation, is associated with plasma de-
fi  ciency of the protein, but so far has 
not been shown to cause disease (  11  ). 
This mutation is of particular interest 
as it is analogous to the Z allele that 
causes polymerization of       1  -antitrypsin. 
The same mutation in the   Drosophila   
serpin necrotic causes temperature-de-
pendent polymerization and inactivation 
of the protein (  12  ). We therefore pre-
dict that episodes of fever will precipi-
tate the inactivation of unstable serpins 
and thus exacerbate the tissue damage 
of the serpinopathies. 
  Tissue damage caused by extracellular 
deposits: mechanism 3 
  Many serpins are synthesized in the liver 
and released into the circulation. Al-
though mutation-induced polymerization 
often results in the retention of the pro-
tein within hepatocytes, some mutant 
protein can traffi   c through the secretory 
pathway and reach the circulation or 
local tissues. This protein often retains 
function as a proteinase inhibitor but still 
carries the mutation and thus the pro-
pensity to form polymers once secreted. 
Indeed, polymers of       1  -antitrypsin, anti-
thrombin, and C1-inhibitor have been 
identifi  ed in the plasma of individuals 
with mutations in these proteins (  13  –  15  ). 
Moreover, polymers of neuroserpin pre-
dominate in the culture media of cells 1532 SERPIN POLYMERS AND DISEASE   | Gooptu and Lomas 
key 358Met residue by superoxide radi-
cals. In addition to exacerbating proteol-
ysis, the lack of active       1  -antitrypsin leads 
to uncontrolled activation of intracellular 
caspase-3 and hence alveolar cell apopto-
sis and emphysema (  28  ). 
  Thus, there is evidence that both 
uncontrolled proteolytic activity due to 
loss of       1  -antitrypsin function (mecha-
nism 2) and tissue damage due to extra-
cellular deposition of Z       1  -antitrypsin 
polymers (mechanism 3) contribute to the 
(  17  ), thereby maximizing damage to the 
extracellular matrix and spreading the fo-
cus of infl  ammation throughout the lob-
ules of the lung. 
  The destructive eff  ects of neutrophil-
derived proteolytic enzymes are amplifi  ed 
in individuals with       1  -antitrypsin defi  -
ciency, as the small amount of mono-
meric Z       1  -antitrypsin that is present is 
less effi   cient at inhibiting neutrophil elas-
tase. The activity of       1  -antitrypsin is likely 
to be further reduced by oxidation of the 
The greatest resistance to diff  usion is 
the interstitium, where Z       1  -antitrypsin 
is con  centrated and where it forms 
polymers. The chemotactic property of 
      1  -antitrypsin polymers can then trap 
neutrophils within the interstitium as 
they migrate from the vascular space to 
the alveolar compartment in response to 
chemokines (  Fig. 2  ). Once neutrophils 
are retained within the interstitium, the 
polymers cause the cells to adhere, de-
granulate, and release proteolytic enzymes 
    Figure 2.         The localization of       1  -antitrypsin polymers and neutrophils in the lung interstitium.   (A) The alveolar wall is composed of structural 
type I (green) and type II (blue) pneumocytes (reference   22  ). These are separated from the capillary endothelium (yellow) by interstitial matrix that is 
maintained by fi  broblasts (red) and also contains macrophages. (B) Neutrophils (light yellow) migrate through the interstitium (arrow) into the lung (black 
oval) in response to infl  ammatory mediators, such as LTB4 (blue), IL-8 (gold), and elastin fragments (black). Interstitial polymers (inset, repeating units of 
blue, red, and yellow) bind to neutrophils and cause them to degranulate, thus amplifying and accelerating tissue destruction in emphysema.     JEM VOL. 205, July 7, 2008  1533
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  Strategies that target the downstream 
eff  ects, rather than the polymer itself, 
provide a third possibility. Given the 
central role of free radicals in emphy-
sema, antioxidant agents are required to 
reduce oxidative stress within the lung. 
Although the current generation of anti-
oxidants is not suffi   ciently potent, they 
may be eff  ective if coadministered with 
agents that block polymer formation 
and/or the interaction of polymers with 
neutrophils. Finally, inhibition of the 
infl  ammatory response by blocking in-
tracellular (NF-    B  –  dependent) and ex-
tracellular pathways that are activated by 
polymers might also be a successful ap-
proach to ameliorating the lung disease 
associated with       1  -antitrypsin defi  ciency. 
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